Exceptional stability of the HLA-DQA1*0102/DQB1*0602 αβ protein dimer, the class II MHC molecule associated with protection from insulin- dependent diabetes mellitus

Journal of Immunology

Volumn 161, Issue 11, 1998, Pages 6439-6445

  Ettinger, Ruth A ^a   Liu, Andrew W ^a   Nepom, Gerald T ^a   Kwok, William W ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b BENAROYA RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIMER; HLA DQ ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ARTICLE; BARE LYMPHOCYTE SYNDROME; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOBLASTOID CELL LINE; PRIORITY JOURNAL; PROTEIN STABILITY;

ALLELES; B-LYMPHOCYTES; CELL LINE, TRANSFORMED; DIABETES MELLITUS, TYPE 1; DIMERIZATION; GENETIC PREDISPOSITION TO DISEASE; HERPESVIRUS 4, HUMAN; HLA-DQ ANTIGENS; HUMANS; PROTEIN DENATURATION; SODIUM DODECYL SULFATE;

EID: 0032400950     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. g7 molecules from non-obese diabetic mice are poor peptide binders. J. Immunol. 156:450.
2. Morris, P., J. Shaman, M. Attaya, M. Amaya, S. Goodman, C. Bergman, J. J. Monaco, and E. Mellins. 1994. An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules. Nature 368:551.
3. Fling, S. P., B. Arp. and D. Pious. 1994. HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells. Nature 368:554.
4. Kovats, S., G. T. Nepom, M. Coleman, B. Nepom. W. W. Kwok, and J. S. Blum. 1995. Deficient antigen-presenting cell function in multiple genetic complementation groups of type II bare lymphocyte syndrome. J. Clin. Invest. 96:217.
5. Miyazaki, T., P. Wolf, S. Tourne, C. Waltzinger, A. Dierich, N. Barois, H. Ploegh, C. Benoist, and D. Mathis. 1996. Mice lacking H2-M complexes, enigmatic elements of the MHC class II peptide-loading pathway. Cell 84:531.
6. Martin, W. D., G. G. Hicks, S. K. Mendiratta, H. I. Leva, H. E. Ruley, and L. Van Kaer. 1996. H2-M mutant mice are defective in the peptide loading of class II molecules, antigen presentation, and T cell repertoire selection. Cell 84:543.
7. Riberdy, J. M., J. R. Newcomb, M. J. Surman, J. A. Barbosa, and P. Cresswell, 1992. HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides. Nalure 360:474.
8. Sette, A., S. Ceman, R. T. Kubo, K. Sakaguchi, E. Appella, D. F. Hunt, T. A. Davis, H. Michel, J. Shabanowitz, R. Rudersdorf, H. M. Grey, and R. DeMars. 1992. Invariant chain peptides in most HLA-DR molecules of an antigen-processing mutant. Science 258:1801.
9. Monji, T., A. L. McCormack, J. R. Yates III, and D. Pious. 1994. Invariant-cognate peptide exchange restores class II dimer stability in HLA-DM mutants. J. Immunol. 153:4468.
10. Vogt, A. B., H. Kropshofer, G. Moldenhauer, and G. J. Hammerling. 1996. Kinetic analysis of peptide loading onto HLA-DR molecules mediated by HLA-DM. Proc. Natl Acad. Sci. USA 93:9724.
11. Weber, D. A., B. D. Evavold, and P. E. Jensen. 1996. Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM. Science 274:618.
12. van Ham, S. M., U. Grüneberg, G. Malcherek, I. Broker, A. Melms, and J. Trowsdale. 1996. Human histocompatibility leukocyte antigen (HLA)-DM edits peptides presented by HLA-DR according to their ligand binding motifs. J. Exp. Med. 184:2019.
13. Katz, J. F., C. Stebbins, E. Appella, and A. J. Sam. 1996. Invariant chain and DM edit self-peptide presentation by major histocompatibility complex (MHC) class II molecules. J. Exp. Med. 184:1747.
14. Sadegh-Nasseri, S., and R. N. Germain. 1991. A role for peptide in determining MHC class II structure. Nature 353:167.
15. Stem, L. J., and D. C. Wiley. 1992. The human class II MHC protein HLA-DR1 assembles as empty αβ heterodimers in the absence of antigenic peptide. Cell 68:465.
16. Mellins, E., L. Smith, B. Arp, T. Corner, E. Cells, and D. Pious. 1990. Defective processing and presentation of exogenous antigens in mutants with normal HLA class II genes. Nature 343:71.
17. Nelson, C. A., S. J. Petzold, and E. R. Unanue. 1994. Peptides determine the lifespan of MHC class II molecules in the antigen-presenting cell. Nature 371:250.
18. Rønningen, K. S., A. Spurkland, B. D. Tait, B. Drummond, C. Lopez-Larrea, F. S. Baranda, M. J. Mendendez-Diaz, S. Caillat-Zucman, G. Beaurain, H.-J. Garchon, et al, 1992. HLA class II associations in insulin-dependent diabetes mellitus among blacks, Caucasoids, and Japanese. In HLA 1991. K. Tsuji, M. Aizawa, and T. Sasazuki, eds. Oxford University Press. New York, p. 713.
19. Nepom, G. T., and H. Erlich. 1991. MHC class-II molecules and autoimmunity. Annu. Rev. Immunol. 9:493.
20. Baisch, J. M., T. Weeks, R. Giles, M. Hoover, P. Stastny, and J. D. Capra. 1990. Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus. N. Engl. J. Med. 322:1836.
21. Kimura, A., R-P. Dong, H. Harada, and T. Sasazuki. 1992. DNA typing of HLA class II genes in B-lymphoblastoid cell lines homozygous for HLA. Tissue Antigens 40:5.
22. Hume, C. R., L. A. Shookster, N. Collins, R. O'Reilly, and J. S. Lee. 1989. Bare lymphocyte syndrome: altered HLA class II expression in B cell lines derived from two patients. Human Immunol. 25:1.
23. Mach, B., V. Steimle, E. Martinez-Soria, and W. Reith. 1996. Regulation of MHC class II genes: lessons from a disease. Annu. Kev. Immunol. 14:301.
24. Kwok, W. W., D. Schwarz, B. S. Nepom, R. A. Hock, P. S. Thurtle, and G. T. Nepom. 1988. HLA-DQ molecules form α-β heterodimers of mixed allotype. J. lmmunol. 141:3123.
25. Spits, H., J. Borst, M. Giphart, J. Coligan, C. Terhorst, and J. E. De Vries. 1984. HLA-DC antigens can serve as recognition elements for human cytotoxic T lymphocytes. Eur. J. Immunol. 14:299.
26. Shookster, L., T. Matsuyama, G. Burmester, and R. Winchester. 1987. Monoclonal antibody 1a3 recognizes a monomorphic epitope unique to DQ molecules. Hum. Immunol. 20:59.
27. Radka, S. F., K. A. Nelson, and J. V. Johnston. 1989. HLA-DQw3-related determinants: analysis of subunit and spatial relationships. Hum. Immunol. 25:225.
28. Petersen, J. S., and T. Dyrberg. 1992. Production of epitope specific monoclonal IgG antibodies to HLA class II molecules by combining in vivo and in vitro immunization. J. Immunol. Methods 151:15.
29. Lampson, L. A., and R. Levy. 1980. Two populations of la-like molecules on a human B cell line. J. Immunol. 125:293.
30. Guy, K., V. Van Heyningen, B. B. Cohen, D. L. Deane, and C. M. Steel. 1982. Differential expression and serologically distinct subpopulations of human Ia antigens detected with monoclonal antibodies to Ia a and β chains. Eur. J. Immunol. 12:942.
31. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248.
32. Sanjeevi, C. B., M. Landin-Olsson, I. Kockum, G. Dahlquist, and Å. Lernmark. 1995. Effects of the second HLA-DQ haplotype on the association with childhood insulin-dependent diabetes mellitus. Tissue Antigens 45:148.
33. Springer, T. A., J. F. Kaufman, L. A. Siddoway, D. L. Mann, and J. L. Strominger. 1977. Purification of HLA-linked B lymphocyte alloantigens in immunologically active form by preparative sodium dodecyl sulfate-gel electrophoresis and studies on their subunit association. J. Biol. Chem. 252:6201.
34. Buckner, J., W. W. Kwok, B. Nepom, and G. T. Nepom. 1996. Modulation of HLA-DQ binding properties by differences in class II dimer stability and pH-dependent peptide interactions. J. Immunol. 157:4940.
35. g7 protein of non-obese diabetic mice. Eur. J. Immunol. 27:2478.
36. Hoover, M. L., and R. T. Marta. 1997. Molecular modelling of HLA-DQ suggests a mechanism of resistance in type I diabetes. Scand. J. Immunol. 45:193.
37. Sanjeevi, C. B , C. DeWeese, M. Landin-Olsson, I. Kockum, G. Dahlquist, Å. Lernmark, and T. P. Lybrand. 1997. Analysis of critical residues of HLA-DQ6 molecules in insulin-dependent diabetes mellitus. Tissue Antigens 50:61.
38. Marsh, S. G. E., and J. G. Bodmer. 1995. HLA class II region nucleotide sequences. Tissue Antigens 45:258.
39. Stebbins, C. C., M. E. Peterson, W. M. Suh, and A. J. Sant. 1996. DM-mediated release of a naturally occurring invariant chain degradation intermediate from MHC class II molecules. J. Immunol. 157:4892.
40. g7. Int. Immunol. 9:43.
41. Nepom, G. T. 1990. A unified hypothesis for the complex genetics of HLA associations with IDDM. Diabetes 39:1153.
42. Schmidt, D., J. Verdaguer, N. Averill, and P. Santamaria. 1997. A mechanism for the major histocompatibility complex-linked resistance to autoimmunity. J. Exp. Med. 186:1059.
43. Lühder, F., J. Katz, C. Benoist, and D. Mathias. 1998. Major histocompatibility complex class II molecules can protect from diabetes by positively selecting T cells with additional specificities. J. Exp. Med. 187:379.
44. Hanson, M. S., M. Cetkovic-Cvrlje, V. K. Ramiya, M. A. Atkinson, N. K. Maclaren, B. Singh, J. F. Elliott, D. V. Serreze, and E. H. Leiter. 1996. Quantitative thresholds of MHC class II I-E expressed on hemopoietically derived antigen-presenting cells in transgenic NOD/Lt mice determine level of diabetes resistance and indicate mechanism of protection. J. Immunol. 157:1279.
45. Alberola-Ila, J., S. Takaki, J. D. Kerner, and R. M. Perlmutter. 1997. Differential signaling by lymphocyte antigen receptors. Annu. Rev. Immunol. 15:125.
46. Denzin, L. K., D. B. Sant'Angelo, C. Hammond, M. J. Surman, and P. Cresswell. 1997. Negative regulation by HLA-DO of MHC class II-restricted antigen processing. Science 278:106.